Tag: Expert Testimony
-
Finance Expert Allowed to Opine on Loss Causation
Stadium Capital (“Stadium”), the Lead Plaintiff in this class action lawsuit, has sued Co-Diagnostics (“CoDx”), its CEO Dwight Egan, and its CFO Brian Brown, for allegedly making false or misleading statements in violation of the Securities Exchange Act of 1934. Defendants filed a motion to exclude the testimony of Stadium’s expert witness, Chad W. Coffman…
-
Law And Legal Expert Was Barred From Opining on the Trust Agreement
The Plaintiff, Christopher Ayash, is a named beneficiary of the Patricia Louise Ayash Living Trust (“Trust”), created by his late mother (“Grantor”) in 2002. The Trust also named two of the Grantor’s other sons as beneficiaries. The Defendants, David Barnette and Karl Hamm, serve as Trustees. The Trustees are directed to divide and hold the…
-
Materials Science Expert’s Testimony on Fire Causation Excluded
Ibrahim Qasim bought a sixty-four ounce container of EcoLogic Bed Bug Killer 2 (“Product”) from Home Depot on August 26, 2019. On September 2, 2019, at 9:00 a.m., Ibrahim sprayed all sixty-four ounces of the product into the living room of the apartment he and Nouh Qasim shared. At 5:00 p.m., as Nouh turned on…
-
Insurance Expert Was Allowed to Opine on Damage Causation
This case involves allegations of underpayment and nonpayment under an insurance policy. Ategrity Specialty Insurance Company issued Policy No. 01-C-PK-P20064154-0 to 707 FWY Investments, LLC with effective dates of September 12, 2022, to September 12, 2023. Plaintiff leased out this structure to commercial tenants. The roof collapsed and then several severe rain and windstorms allowed…
-
Life Care Planning Expert’s Testimony on Future Care Limited
On October 27, 2022, a three-vehicle collision occurred on Interstate-10 in Phoenix, Arizona. Defendant Eduardo Serrato was operating a tractor trailer when he struck the rear of a Dodge Dart, killing a non-party individual inside the vehicle. The Dodge Dart was pushed across two lanes, and it impacted the tractor trailer containing Plaintiffs Robert Hanifon…
-
Actuarial Science Expert Was Allowed to Opine on the Resulting Damage
This action arises from a dispute about the payment of service fees by Bulldog National Risk Retention Group (“Bulldog”) to Plaintiff GB Group. Specifically, the dispute centers on a Service Agreement between GB Group and Bulldog, as well as an Addendum thereto entered into in July 2018 and August 2020. To begin with, GB Group…
-
The Law Enforcement Expert Was Allowed to Opine on Pennsylvania State Police Policy
The Defendants are Pennsylvania State Police Troopers accused of using excessive force when they served a 302 warrant on Plaintiff Carl Giuli based on his wife’s reports that Giuli was experiencing a mental health crisis. While serving the warrant, an altercation occurred in Giuli’s house involving Giuli and Pennsylvania State Police Troopers Joseph Montagna and…
-
Intellectual Property Expert’s Fair Use Opinion Admitted
The Volga German people are individuals of German origin who moved to the Volga region of Russia in the eighteenth century. Many of the descendants of the Volga German people have moved to other parts of the world after persecution of Germans in Russia. There is a sizable Volga German diasporain the American Midwest. Plaintiff…
-
Computer Science Expert’s Testimony on the Value of Data Admitted
This class action lawsuit arises out of Amazon’s practice of using smart-speaker technology (“Alexa”) to surreptitiously: (a) intercept; (b) eavesdrop; (c) record; (d) disclose; or (e) use millions of Americans’ voices and communications, all without their knowledge or consent. Such conduct blatantly violates Washington’s wiretapping law, which applies nationwide to Plaintiffs and all members of…
-
Pharmacoeconomics Expert’s Pricing Opinions Admitted
This is an antitrust action filed by Plaintiffs CareFirst of Maryland, Inc., Group Hospitalization and Medical Services Inc., and CareFirst Bluechoice Inc. (collectively, “CareFirst”) alleging that Defendants Johnson & Johnson and Janssen Biotech, Inc. (collectively, “J&J”) used monopoly power to unlawfully delay the introduction of biosimilar competitors for their drug ustekinumab (sold under the brand…
